Outpatient Treatment of Severe and Enduring Anorexia Nervosa

Helsinki University Central Hospital20 enrolled

Overview

Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Anorexia

Interventions

Outpatient treatment of severe and enduring anorexia nervosaBEHAVIORAL

A novel outpatient treatment of severe and enduring anorexia nervosa, aiming at enhancing quality of life and minimizing harm

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Age ≥ 18 years * A referral resulting in an assessment or treatment period at the unit for patients with severe and enduring anorexia nervosa at the HUS Helsinki University Hospital between May 2017 and May 2022.

Locations (1)

HUS Syömishäiriöyksikkö

Helsinki, PL 282, Finland

Outcomes

Primary Outcomes

How the treatment goals were met

Whether or not the patients' individual treatment goals, defined at the beginning of treatment, had been met, partly met, or not met at the end of treatment.

Time frame: At the end of treatment, an average of 15.4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.